Norton Rose Fulbright has advised Canadian cannabis company Khiron Life Sciences on the deal. Osborne Clarke has advised PharmaDrug, Inc..Khiron Life Sciences acquired all shares in…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Giulia Di Palma
…
This content is for Standard 1 Year members only. LoginJoin Now